34
Views
113
CrossRef citations to date
0
Altmetric
Cell Growth and Development

A Novel Mechanism for Wnt Activation of Canonical Signaling through the LRP6 Receptor

, , &
Pages 5825-5835 | Received 10 Feb 2003, Accepted 20 May 2003, Published online: 27 Mar 2023
 

Abstract

LDL receptor-related protein 6 (LRP6) is a Wnt coreceptor in the canonical signaling pathway, which plays essential roles in embryonic development. We demonstrate here that wild-type LRP6 forms an inactive dimer through interactions mediated by epidermal growth factor repeat regions within the extracellular domain. A truncated LRP6 comprising its transmembrane and cytoplasmic domains is expressed as a constitutively active monomer whose signaling ability is inhibited by forced dimerization. Conversely, Wnts are shown to activate canonical signaling through LRP6 by inducing an intracellular conformational switch which relieves allosteric inhibition imposed on the intracellular domains. Thus, Wnt canonical signaling through LRP6 establishes a novel mechanism for receptor activation which is opposite to the general paradigm of ligand-induced receptor oligomerization.

ACKNOWLEDGMENTS

We thank F. Hess for generously providing LRP6 cDNA, F. Costantini for myc-tagged Axin cDNA, and R. Hazan for Flag-tagged FGFR2 cDNA. We are grateful to A. Gazit and A. Yaniv for helpful discussion.

This work was supported by NCI grant CA71672-04 (S.A.A.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.